Colorectal Cancer Alone Shows a Distinct Microbial Fingerprint, Study of 11,735 Tumors Finds
Routine tumor genome sequencing could double as a low‑cost screen for oncogenic microbes.
Overview
- University of East Anglia researchers reanalyzed Genomics England whole‑genome data spanning 11,735 samples across 22 cancers from more than 9,000 patients.
- Only colorectal tumors carried a specific microbial community that could accurately distinguish them from other tumor types.
- The findings challenge earlier claims that every cancer type has its own microbial signature.
- Tumor sequencing also identified clinically relevant viruses, including HPV in oral cancers and rare HTLV‑1 infections that may otherwise go undetected.
- Bacterial signals in some sarcomas correlated with survival outcomes, highlighting prognostic potential that requires further validation as genomic testing expands in clinics.